These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 37910529)

  • 1. Effect of safranal or candesartan on 3-nitropropionicacid-induced biochemical, behavioral and histological alterations in a rat model of Huntington's disease.
    Shehata NI; Abd El-Salam DM; Hussein RM; Rizk SM
    PLoS One; 2023; 18(11):e0293660. PubMed ID: 37910529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Novel Pharmacological Protective Role for Safranal in an Animal Model of Huntington's Disease.
    Fotoohi A; Moloudi MR; Hosseini S; Hassanzadeh K; Feligioni M; Izadpanah E
    Neurochem Res; 2021 Jun; 46(6):1372-1379. PubMed ID: 33611726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of rutin against a mitochondrial toxin, 3-nitropropionicacid induced biochemical, behavioral and histological alterations-a pilot study on Huntington's disease model in rats.
    Suganya SN; Sumathi T
    Metab Brain Dis; 2017 Apr; 32(2):471-481. PubMed ID: 27928694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Possible neuroprotective effect of Withania somnifera root extract against 3-nitropropionic acid-induced behavioral, biochemical, and mitochondrial dysfunction in an animal model of Huntington's disease.
    Kumar P; Kumar A
    J Med Food; 2009 Jun; 12(3):591-600. PubMed ID: 19627208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroprotective activity of tetramethylpyrazine against 3-nitropropionic acid induced Huntington's disease-like symptoms in rats.
    Danduga RCSR; Dondapati SR; Kola PK; Grace L; Tadigiri RVB; Kanakaraju VK
    Biomed Pharmacother; 2018 Sep; 105():1254-1268. PubMed ID: 30021362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Levothyroxine attenuates behavioral impairment and improves oxidative stress and histological alteration 3-nitropropionic acid induced experimental Huntington's disease in rats.
    Badini F; Bayrami A; Mirshekar MA; Shahraki S; Fanaei H
    Behav Brain Res; 2024 Mar; 461():114864. PubMed ID: 38220060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Naringenin mitigates behavioral alterations and provides neuroprotection against 3-nitropropinoic acid-induced Huntington's disease like symptoms in rats.
    Salman M; Sharma P; Alam MI; Tabassum H; Parvez S
    Nutr Neurosci; 2022 Sep; 25(9):1898-1908. PubMed ID: 33856270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of LOX/COX pathways in 3-nitropropionic acid-induced Huntington's disease-like symptoms in rats: protective effect of licofelone.
    Kumar P; Kalonia H; Kumar A
    Br J Pharmacol; 2011 Sep; 164(2b):644-54. PubMed ID: 21486276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. L-theanine, a Component of Green Tea Prevents 3-Nitropropionic Acid (3-NP)-Induced Striatal Toxicity by Modulating Nitric Oxide Pathway.
    Jamwal S; Kumar P
    Mol Neurobiol; 2017 Apr; 54(3):2327-2337. PubMed ID: 26957301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Probucol increases striatal glutathione peroxidase activity and protects against 3-nitropropionic acid-induced pro-oxidative damage in rats.
    Colle D; Santos DB; Moreira EL; Hartwig JM; dos Santos AA; Zimmermann LT; Hort MA; Farina M
    PLoS One; 2013; 8(6):e67658. PubMed ID: 23799154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroprotective effects of levothyroxine on cognition deficits and memory in an experimental model of Huntington's disease in rats: An electrophysiological study.
    Badini F; Mirshekar MA; Shahraki S; Fanaei H; Bayrami A
    Naunyn Schmiedebergs Arch Pharmacol; 2024 Aug; 397(8):5939-5951. PubMed ID: 38372755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ADIOL protects against 3-NP-induced neurotoxicity in rats: Possible impact of its anti-oxidant, anti-inflammatory and anti-apoptotic actions.
    Hanna DM; Tadros MG; Khalifa AE
    Prog Neuropsychopharmacol Biol Psychiatry; 2015 Jul; 60():36-51. PubMed ID: 25689821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of Ginkgo biloba extract on 3-nitropropionic acid-induced neurotoxicity in rats.
    Mahdy HM; Tadros MG; Mohamed MR; Karim AM; Khalifa AE
    Neurochem Int; 2011 Nov; 59(6):770-8. PubMed ID: 21827809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel therapeutic application of solid lipid nanoparticles encapsulated thymoquinone (TQ-SLNs) on 3-nitroproponic acid induced Huntington's disease-like symptoms in wistar rats.
    Ramachandran S; Thangarajan S
    Chem Biol Interact; 2016 Aug; 256():25-36. PubMed ID: 27206696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroprotective effect of solanesol against 3-nitropropionic acid-induced Huntington's disease-like behavioral, biochemical, and cellular alterations: Restoration of coenzyme-Q10-mediated mitochondrial dysfunction.
    Mehan S; Monga V; Rani M; Dudi R; Ghimire K
    Indian J Pharmacol; 2018; 50(6):309-319. PubMed ID: 30783323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroprotective effect of taurine in 3-nitropropionic acid-induced experimental animal model of Huntington's disease phenotype.
    Tadros MG; Khalifa AE; Abdel-Naim AB; Arafa HM
    Pharmacol Biochem Behav; 2005 Nov; 82(3):574-82. PubMed ID: 16337998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Piperine mitigates behavioral impairments and provides neuroprotection against 3-nitropropinoic acid-induced Huntington disease-like symptoms.
    Salman M; Tabassum H; Parvez S
    Nutr Neurosci; 2022 Jan; 25(1):100-109. PubMed ID: 32093571
    [No Abstract]   [Full Text] [Related]  

  • 18. Mitochondrial cofactors in experimental Huntington's disease: behavioral, biochemical and histological evaluation.
    Mehrotra A; Sandhir R
    Behav Brain Res; 2014 Mar; 261():345-55. PubMed ID: 24393741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroprotective effect of nicotine against 3-nitropropionic acid (3-NP)-induced experimental Huntington's disease in rats.
    Tariq M; Khan HA; Elfaki I; Al Deeb S; Al Moutaery K
    Brain Res Bull; 2005 Sep; 67(1-2):161-8. PubMed ID: 16140176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroprotective effect of lutein against 3-nitropropionic acid-induced Huntington's disease-like symptoms: possible behavioral, biochemical, and cellular alterations.
    Binawade Y; Jagtap A
    J Med Food; 2013 Oct; 16(10):934-43. PubMed ID: 24138168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.